IBDEI2ZY ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,47855,1,4,0)
 ;;=4^R21.
 ;;^UTILITY(U,$J,358.3,47855,2)
 ;;=^5019283
 ;;^UTILITY(U,$J,358.3,47856,0)
 ;;=L71.9^^185^2412^93
 ;;^UTILITY(U,$J,358.3,47856,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47856,1,3,0)
 ;;=3^Rosacea,Unspec
 ;;^UTILITY(U,$J,358.3,47856,1,4,0)
 ;;=4^L71.9
 ;;^UTILITY(U,$J,358.3,47856,2)
 ;;=^5009276
 ;;^UTILITY(U,$J,358.3,47857,0)
 ;;=L82.0^^185^2412^94
 ;;^UTILITY(U,$J,358.3,47857,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47857,1,3,0)
 ;;=3^Seborrheic Keratosis,Inflamed
 ;;^UTILITY(U,$J,358.3,47857,1,4,0)
 ;;=4^L82.0
 ;;^UTILITY(U,$J,358.3,47857,2)
 ;;=^303311
 ;;^UTILITY(U,$J,358.3,47858,0)
 ;;=L82.1^^185^2412^95
 ;;^UTILITY(U,$J,358.3,47858,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47858,1,3,0)
 ;;=3^Seborrheic Keratosis,Other
 ;;^UTILITY(U,$J,358.3,47858,1,4,0)
 ;;=4^L82.1
 ;;^UTILITY(U,$J,358.3,47858,2)
 ;;=^303312
 ;;^UTILITY(U,$J,358.3,47859,0)
 ;;=L92.9^^185^2412^42
 ;;^UTILITY(U,$J,358.3,47859,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47859,1,3,0)
 ;;=3^Granulomatous Disorder of Skin,Unspec
 ;;^UTILITY(U,$J,358.3,47859,1,4,0)
 ;;=4^L92.9
 ;;^UTILITY(U,$J,358.3,47859,2)
 ;;=^5009466
 ;;^UTILITY(U,$J,358.3,47860,0)
 ;;=L98.9^^185^2412^101
 ;;^UTILITY(U,$J,358.3,47860,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47860,1,3,0)
 ;;=3^Skin Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,47860,1,4,0)
 ;;=4^L98.9
 ;;^UTILITY(U,$J,358.3,47860,2)
 ;;=^5009595
 ;;^UTILITY(U,$J,358.3,47861,0)
 ;;=L08.9^^185^2412^104
 ;;^UTILITY(U,$J,358.3,47861,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47861,1,3,0)
 ;;=3^Skin Infection,Local,Unspec
 ;;^UTILITY(U,$J,358.3,47861,1,4,0)
 ;;=4^L08.9
 ;;^UTILITY(U,$J,358.3,47861,2)
 ;;=^5009082
 ;;^UTILITY(U,$J,358.3,47862,0)
 ;;=L57.9^^185^2412^97
 ;;^UTILITY(U,$J,358.3,47862,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47862,1,3,0)
 ;;=3^Skin Changes d/t Chr Expsr to Nonionizing Radiation,Unspec
 ;;^UTILITY(U,$J,358.3,47862,1,4,0)
 ;;=4^L57.9
 ;;^UTILITY(U,$J,358.3,47862,2)
 ;;=^5009227
 ;;^UTILITY(U,$J,358.3,47863,0)
 ;;=L90.9^^185^2412^99
 ;;^UTILITY(U,$J,358.3,47863,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47863,1,3,0)
 ;;=3^Skin Disorder,Atrophic,Unspec
 ;;^UTILITY(U,$J,358.3,47863,1,4,0)
 ;;=4^L90.9
 ;;^UTILITY(U,$J,358.3,47863,2)
 ;;=^5009458
 ;;^UTILITY(U,$J,358.3,47864,0)
 ;;=L91.9^^185^2412^100
 ;;^UTILITY(U,$J,358.3,47864,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47864,1,3,0)
 ;;=3^Skin Disorder,Hypertrophic,Unspec
 ;;^UTILITY(U,$J,358.3,47864,1,4,0)
 ;;=4^L91.9
 ;;^UTILITY(U,$J,358.3,47864,2)
 ;;=^5009461
 ;;^UTILITY(U,$J,358.3,47865,0)
 ;;=R20.0^^185^2412^96
 ;;^UTILITY(U,$J,358.3,47865,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47865,1,3,0)
 ;;=3^Skin Anesthesia
 ;;^UTILITY(U,$J,358.3,47865,1,4,0)
 ;;=4^R20.0
 ;;^UTILITY(U,$J,358.3,47865,2)
 ;;=^5019278
 ;;^UTILITY(U,$J,358.3,47866,0)
 ;;=R20.3^^185^2412^102
 ;;^UTILITY(U,$J,358.3,47866,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47866,1,3,0)
 ;;=3^Skin Hyperesthesia
 ;;^UTILITY(U,$J,358.3,47866,1,4,0)
 ;;=4^R20.3
 ;;^UTILITY(U,$J,358.3,47866,2)
 ;;=^60011
 ;;^UTILITY(U,$J,358.3,47867,0)
 ;;=R20.1^^185^2412^103
 ;;^UTILITY(U,$J,358.3,47867,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47867,1,3,0)
 ;;=3^Skin Hypoesthesia
 ;;^UTILITY(U,$J,358.3,47867,1,4,0)
 ;;=4^R20.1
 ;;^UTILITY(U,$J,358.3,47867,2)
 ;;=^5019279
 ;;^UTILITY(U,$J,358.3,47868,0)
 ;;=R20.2^^185^2412^105
